当前位置: 首页 > 期刊 > 《中国药房》 > 2025年第14期
编号:2390019
中药调控NF-κB信号通路防治心肌梗死的研究进展
http://www.100md.com 2025年8月18日 中国药房 2025年第14期
     中图分类号R965;R285 文献标志码A 文章编号 1001-0408(2025)14-1807-06

    nOI 106030/iiccn 1001 040820251421

    ABSTRACTMyocardialinfarction(MI)referstoanacuteclinicalsyndromeofmyocardialnecrosisduetopersistentischemia and hypoxia,resulting from the sharp reduction or interuption of coronary blood flow.Nuclear factor κB (NF- κB )isthekey factorininducinginflammatorresponse,anditisinvolvedintheproductionofpro-inflammatoryfactorsandmyocardialcel apoptosis.This article systematically describes the molecular regulation mechanism of the NF- κB signaling pathway in MI,and reviewstherelatedresearchonthepreventionandtreatmentofMIthrough theregulationofthissignaling pathwaybyactive ingredientsandcompoundformulasfromtraditionalChinesemedicine(TCM).IthasbeenfoundthatactiveingredientsfromTCM, such as ginsenoside Rg3 ,baicalein,curcumin,tanshinone IA ,gambogic acid,as well as compound formulas,including Qili qiangxincapsules,Yiqi huoxuedecoction,Lingbao huxindan,Danhong injection,Baoyuandecoctioncombinedwith Taohong siwudecoction,canimproveyocardial fibrosis,aleviate inflammatoryresponses ......

您现在查看是摘要页,全文长 22947 字符